Literature DB >> 9637702

In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.

M G Revello1, E Percivalle, E Arbustini, R Pardi, S Sozzani, G Gerna.   

Abstract

Immunocompromised patients with disseminated human cytomegalovirus (HCMV) infection have circulating PMN carrying HCMV pp65 (antigenemia), infectious virus (viremia), and viral DNA (leukoDNAemia). Because HCMV does not fully replicate in PMN, it is generally hypothesized that virions and viral materials are taken up by phagocytosis from fully permissive HCMV-infected endothelial cells. However, no experimental evidence has ever been provided for these PMN-endothelium interactions. PMN from 11 donors were cocultured with endothelial cells infected with an endothelium-adapted HCMV strain and with human fibroblasts infected with low-passaged clinical and laboratory-adapted HCMV strains. pp65-positive PMN were detected after coculture with both HCMV-infected endothelial and fibroblast cells, provided that wild and not laboratory-adapted strains were used. In addition, cocultured PMN carried infectious virus as demonstrated by virus isolation and presence of complete virus particles by electron microscopy. Moreover, high levels of viral DNA were consistently detected by quantitative PCR in cocultured PMN. Thus, we have generated in vitro the three most important viral parameters detected in patients with disseminated HCMV infection (antigenemia, viremia, and leukoDNAemia). The failure of laboratory-adapted HCMV strain to induce this phenomenon demonstrates that important modifications have occurred in attenuated viral strains affecting basic biological functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637702      PMCID: PMC508859          DOI: 10.1172/JCI1633

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells.

Authors:  A H Span; C P Van Boven; C A Bruggeman
Journal:  Eur J Clin Invest       Date:  1989-12       Impact factor: 4.686

2.  Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells.

Authors:  K Radsak; R Fuhrmann; R P Franke; D Schneider; A Kollert; K H Brücher; D Drenckhahn
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  Virus infection of endothelial cells.

Authors:  H M Friedman; E J Macarak; R R MacGregor; J Wolfe; N A Kefalides
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

6.  Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors:  G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization.

Authors:  L W Turtinen; R Saltzman; M C Jordan; A T Haase
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

8.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells.

Authors:  W J Waldman; W H Roberts; D H Davis; M V Williams; D D Sedmak; R E Stephens
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

View more
  25 in total

1.  Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

Authors:  G Gerna; E Percivalle; F Baldanti; S Sozzani; P Lanzarini; E Genini; D Lilleri; M G Revello
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains.

Authors:  M Kahl; D Siegel-Axel; S Stenglein; G Jahn; C Sinzger
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion.

Authors:  Marco Patrone; Massimiliano Secchi; Loretta Fiorina; Mariagrazia Ierardi; Gabriele Milanesi; Andrea Gallina
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Cytomegalovirus encodes a potent alpha chemokine.

Authors:  M E Penfold; D J Dairaghi; G M Duke; N Saederup; E S Mocarski; G W Kemble; T J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines.

Authors:  K Frenzel; S Ganepola; D Michel; E Thiel; D H Krüger; L Uharek; J Hofmann
Journal:  Med Microbiol Immunol       Date:  2012-08       Impact factor: 3.402

6.  Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.

Authors:  G Gerna; F Baldanti; D Lilleri; M Parea; E Alessandrino; A Pagani; F Locatelli; J Middeldorp; M G Revello
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.

Authors:  B W A van der Strate; J L Hillebrands; S S Lycklama à Nijeholt; L Beljaars; C A Bruggeman; M J A Van Luyn; J Rozing; T H The; D K F Meijer; G Molema; M C Harmsen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Authors:  Gabriele Hahn; Maria Grazia Revello; Marco Patrone; Elena Percivalle; Giulia Campanini; Antonella Sarasini; Markus Wagner; Andrea Gallina; Gabriele Milanesi; Ulrich Koszinowski; Fausto Baldanti; Giuseppe Gerna
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.

Authors:  Giuseppe Gerna; Elena Percivalle; Laurent Perez; Antonio Lanzavecchia; Daniele Lilleri
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.